Barbara Ann Karmanos Cancer Hospital

Detroit, Michigan 48201

3 studies enrolling now · 10 studies all time

What they study most

Anemia, Clear Cell Renal Cell Carcinoma, Endometrial Cancer, Follicular Lymphoma, Head and Neck Cancer, Lymphoma, Marginal Zone Lymphoma, Metastatic Cholangiocarcinoma, Metastatic Melanoma, Multiple Myeloma, Myelodysplastic Syndromes, Non Small Cell Lung Cancer

Studies at this site

• A Study of Tolododekin Alfa (ANK-101) in Combination With an Anti-PD-1/PD-L1 Antibody in Participants With Advanced Non-Small Cell Lung Cancer — Recruiting now
• A Study of Lifileucel (Tumor-infiltrating Lymphocytes) in Adults With Advanced Endometrial Cancer. — Recruiting now
• Safety and Efficacy of Retifanlimab (INCMGA00012) Alone or in Combination With Other Therapies in Participants With Advanced or Metastatic Endometrial Cancer Who Have Progressed on or After Platinum-based Chemotherapy. — Completed
• Expanded Access Program of AMTAGVI That is Out of Specification for Commercial Release — Available (expanded access)
• Study of Retinfanlimab in Combination With INCAGN02385 and INCAGN02390 as First-Line Treatment in Participants With PD-L1-Positive (CPS ≥ 1) Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck — Running, not enrolling
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• To Assess the Safety and Tolerability of INCB000928 in Participants With Myelodysplastic Syndromes or Multiple Myeloma — Stopped early
• A Study to Evaluate the Efficacy and Safety of Pemigatinib Versus Chemotherapy in Unresectable or Metastatic Cholangiocarcinoma — Stopped early
• A Study of INCB050465 in Relapsed or Refractory Follicular Lymphoma — Completed
• 89Zr-TLX250 for PET/CT Imaging of ccRCC- ZIRCON Study — Completed